Through careful analysis of an HTC’s payer mix, patient factor usage, assay management, product pricing, shipping costs, ancillary supplies, labor costs, we help Alliance members to develop business proformas and evaluate the potential of the 340B program.
In addition, we help members review and evaluate payer contracts to identify successes and potential opportunities for improvements that benefit both the HTC and payer.